IL124568A0 - Pharmaceutical compositions comprising flurbiprofen - Google Patents

Pharmaceutical compositions comprising flurbiprofen

Info

Publication number
IL124568A0
IL124568A0 IL12456896A IL12456896A IL124568A0 IL 124568 A0 IL124568 A0 IL 124568A0 IL 12456896 A IL12456896 A IL 12456896A IL 12456896 A IL12456896 A IL 12456896A IL 124568 A0 IL124568 A0 IL 124568A0
Authority
IL
Israel
Prior art keywords
flurbiprofen
pharmaceutical compositions
sugar
treatment
relates
Prior art date
Application number
IL12456896A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of IL124568A0 publication Critical patent/IL124568A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
IL12456896A 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen IL124568A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9523833.3A GB9523833D0 (en) 1995-11-22 1995-11-22 Medical treatment
PCT/EP1996/005208 WO1997018802A1 (en) 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen

Publications (1)

Publication Number Publication Date
IL124568A0 true IL124568A0 (en) 1998-12-06

Family

ID=10784245

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12456896A IL124568A0 (en) 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen

Country Status (21)

Country Link
US (2) US5889057A (cs)
EP (1) EP0862424B1 (cs)
CN (1) CN1148177C (cs)
AT (1) ATE252382T1 (cs)
AU (1) AU707749B2 (cs)
BG (1) BG64166B1 (cs)
CA (1) CA2238271C (cs)
CZ (1) CZ289643B6 (cs)
DE (1) DE69630460T2 (cs)
DK (1) DK0862424T3 (cs)
ES (1) ES2208768T3 (cs)
GB (1) GB9523833D0 (cs)
HU (1) HU225235B1 (cs)
IL (1) IL124568A0 (cs)
NO (1) NO317287B1 (cs)
NZ (1) NZ322933A (cs)
PT (1) PT862424E (cs)
RU (1) RU2203655C2 (cs)
SK (1) SK284092B6 (cs)
UA (1) UA46807C2 (cs)
WO (1) WO1997018802A1 (cs)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
AU7916798A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
WO1998052540A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
WO2000069470A2 (en) * 1999-05-17 2000-11-23 Aesgen, Inc. Improved cellular uptake of bioactive agents
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
IL161991A0 (en) * 2001-11-13 2005-11-20 Pharmacia Corp Oral dosage form of a sulfonamide prodrug such as parecoxib
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
CA2493764C (en) * 2002-08-01 2011-05-24 Aesgen, Inc. Improved treatment of cancer with glutamine
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
US20040265359A1 (en) * 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
JP2007528857A (ja) * 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
AU2006272760A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
KR20080034166A (ko) * 2005-11-02 2008-04-18 테이코쿠 팔마 유에스에이, 인코포레이티드 감각기관 수용성 이부프로펜 경구 투약 제형 및 동일물의제조 및 사용 방법
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
AU2008279414A1 (en) * 2007-07-23 2009-01-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
PL2432454T3 (pl) 2009-05-19 2017-10-31 Neuroderm Ltd Kompozycje do ciągłego podawania inhibitorów dopa-dekarboksylazy
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
PT3326615T (pt) * 2010-11-15 2020-03-23 Neuroderm Ltd Administração continua de l-dopa, inibidores de dopa descarboxilase, inibidores de catecol-o-metil transferase e composições para os mesmos
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
WO2013183055A1 (en) 2012-06-05 2013-12-12 Neuroderm Ltd Compositions comprising apomorphine and organic acids and uses thereof
GB201216893D0 (en) 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
EP3116475B1 (en) 2014-03-13 2020-11-04 Neuroderm Ltd Dopa decarboxylase inhibitor compositions
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
CN110812331A (zh) * 2018-08-10 2020-02-21 北京普德康利医药科技发展有限公司 一种氟比洛芬咽部滞留颗粒
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
CN115536525B (zh) * 2022-09-23 2024-02-23 南京知和医药科技有限公司 一种s-（+）-氟比洛芬盐及其制备方法、药物组合物和用途
US12161612B2 (en) 2023-04-14 2024-12-10 Neuroderm, Ltd. Methods and compositions for reducing symptoms of Parkinson's disease

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1091403A (en) * 1964-01-24 1967-11-15 Boots Pure Drug Co Ltd Therapeutically active phenylalkane derivatives
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
ZA869433B (en) * 1985-12-16 1988-07-27 Cilag Ag Non-irritating suprofen solution
EP0321505A1 (en) * 1986-10-22 1989-06-28 The Upjohn Company Treatment of gingivitis with ibuprofen or flurbiprofen
JPS63156715A (ja) * 1986-12-19 1988-06-29 Teisan Seiyaku Kk 即効性の徐放化製剤
JP2540581B2 (ja) * 1988-02-04 1996-10-02 三省製薬株式会社 外用剤
US4931473A (en) * 1989-02-15 1990-06-05 Richardson-Vicks Inc. Anesthetic oral compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
JP3029456B2 (ja) * 1989-08-17 2000-04-04 セプラカー・インコーポレーテツド Ｓ（＋）フルルビプロフエンまたはケトプロフエンを含有している口腔組成物
JP2738092B2 (ja) * 1989-11-17 1998-04-08 ライオン株式会社 口腔用組成物
GB8928196D0 (en) * 1989-12-13 1990-02-14 Merrell Dow Pharmaceuticals Li Pharmaceutical lozenges
JPH0426618A (ja) * 1990-05-21 1992-01-29 Japan Tobacco Inc トローチ剤
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
JPH07506839A (ja) * 1992-12-04 1995-07-27 メイヤー・ファーマシューティカル・ラボラトリース・インコーポレーテッド スプレー可能な鎮痛剤組成物およびその使用方法
WO1994014476A1 (en) * 1992-12-21 1994-07-07 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
BR9508671A (pt) * 1994-09-02 1998-01-06 Univ Virginia Commonwealth Método de alívio da dor e composição terapêutica
US5567733B1 (en) * 1995-04-27 1999-08-24 Jon G Dishler Irritation relief using nonsteroidal anti-inflammatory compounds
WO1997002273A1 (en) * 1995-07-05 1997-01-23 The Procter & Gamble Company Warming compounds
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
DE69732412T2 (de) * 1996-04-12 2006-01-05 Novadel Pharma Inc. Bukales, polares spray

Also Published As

Publication number Publication date
BG102526A (en) 1999-02-26
AU707749B2 (en) 1999-07-22
CZ289643B6 (cs) 2002-03-13
NO982294L (no) 1998-07-20
PT862424E (pt) 2004-02-27
HUP0000180A3 (en) 2001-10-29
US5889057A (en) 1999-03-30
DE69630460D1 (de) 2003-11-27
GB9523833D0 (en) 1996-01-24
CN1148177C (zh) 2004-05-05
NO982294D0 (no) 1998-05-20
CN1207677A (zh) 1999-02-10
RU2203655C2 (ru) 2003-05-10
HU225235B1 (en) 2006-08-28
HUP0000180A2 (hu) 2000-08-28
CZ156598A3 (cs) 1998-08-12
DK0862424T3 (da) 2003-12-29
CA2238271A1 (en) 1997-05-29
SK284092B6 (sk) 2004-09-08
US6166083A (en) 2000-12-26
EP0862424A1 (en) 1998-09-09
DE69630460T2 (de) 2004-08-19
NZ322933A (en) 2000-02-28
NO317287B1 (no) 2004-10-04
CA2238271C (en) 2008-08-12
WO1997018802A1 (en) 1997-05-29
BG64166B1 (bg) 2004-03-31
EP0862424B1 (en) 2003-10-22
AU2611997A (en) 1997-06-11
ES2208768T3 (es) 2004-06-16
ATE252382T1 (de) 2003-11-15
UA46807C2 (uk) 2002-06-17
SK66598A3 (en) 1998-12-02

Similar Documents

Publication Publication Date Title
IL124568A0 (en) Pharmaceutical compositions comprising flurbiprofen
DK0963200T3 (da) Præparater til inhibering af angiogenese omfattende thalidomid og et NSAID
EP0402955A3 (en) Administration tool for the introduction of solid medication.
NO20011062D0 (no) Farmasøytisk sammensetning og matvaresupplement
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
EP0788359A4 (en) AGENTS FOR THE PRODUCTION OF MEDICINES FOR TREATING VARIOUS REFRACTORY DISORDER
DK0915898T3 (da) Krystalform I af clarithromycin
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
AU5402296A (en) Pharmaceutical composition for transdermic administration
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
IL119989A0 (en) Pharmaceutical compositions for oral treatment of multiple sclerosis
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
EP0657167A3 (fr) Application de l'oenothéine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, les compositions pharmaceutiques le contenant et un procédé de préparation à partir d'Epilobium Parviflorum.
ATE360428T1 (de) Analgetisches arzneimittel
AU8471491A (en) Oligosaccharide derivatives
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
IL125441A0 (en) Novel diphenyl stilbenes and pharmaceutical compositions thereof for treatment of cox-2 mediated diseases
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
IL127143A0 (en) Phospholipid terivatives of non-steroidal anti inflammatory drugs
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
BG104427A (en) Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
FR2759587B1 (fr) Composition pharmaceutique pour l'administration buccale de thiocolchicoside
FR2711524B1 (fr) Procédé de préparation de compositions orales contenant des quinolones.
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees